With the analysis among 2,738 patents, we discovered top 453 key players by total patent application. Incyte Corp., Bristol Myers Squibb Co., Actelion Pharmaceuticals Ltd. are dominant in this area. They take 17.86% of the total patent filing.
Delaware, United States
Patent: 179
New York, United States
Patent: 169
Actelion Pharmaceuticals Ltd.
Basel-Landschaft, Switzerland
Patent: 141
California, United States
Patent: 85
Aurigene Discovery Technologies Ltd.
Karnataka, India
Patent: 74
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 43
Idorsia Pharmaceuticals Ltd.
3M Innovative Properties Co.
Minnesota, United States
Patent: 42
New Jersey, United States
Patent: 37
Immodulon Therapeutics Ltd.
With the analysis among 65 patents, we discovered top 24 start-ups by total patent application. Nouscom AG, Nutcracker Therapeutics, Inc., Institut National de la Santé et de la Recherche Médicale are active in this area.
Basel-Stadt, Switzerland
Patent: 9
Nutcracker Therapeutics, Inc.
California, United States
Patent: 8
Institut National de la Santé et de la Recherche Médicale
SciCann Therapeutics, Inc.
Gammadelta Therapeutics Ltd.
Checkmate Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 3
Massachusetts, United States
Patent: 3
OriCell Therapeutics Co.,Ltd.
Washington, United States
Patent: 2
With the analysis among related 1,369 patents applied in the last 5 years. We discover 338 most active companies in this area. The fast-growing Incyte Corp., ChemoCentryx, Inc., Bristol Myers Squibb Co. take 20.75% of patent filing during this period.
Delaware, United States
Patent: 127
California, United States
Patent: 81
New York, United States
Patent: 76
Sichuan Sheng, China
Patent: 34
Betta Pharmaceuticals Co., Ltd.
Zhejiang Sheng, China
Patent: 33
California, United States
Patent: 23
Immodulon Therapeutics Ltd.
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 18
Advagene Biopharma Co., Ltd.
Taiwan Province, China
Patent: 17
With the analysis among related 1,369 patents in last 5 years, we discover 248 new entrants. HitGen, Inc., Betta Pharmaceuticals Co., Ltd., Advagene Biopharma Co., Ltd. are the most active new entrants in this area.
Sichuan Sheng, China
Patent: 34
Betta Pharmaceuticals Co., Ltd.
Zhejiang Sheng, China
Patent: 33
Advagene Biopharma Co., Ltd.
Taiwan Province, China
Patent: 17
Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd.
Shanghai Shi, China
Patent: 11
Shenzhen Chipscreen Biosciences Co., Ltd.
Guangdong Sheng, China
Patent: 11
ZURICH, Switzerland
Patent: 10
Basel-Stadt, Switzerland
Patent: 9
Massachusetts, United States
Patent: 9
Nutcracker Therapeutics, Inc.
California, United States
Patent: 8
With the analysis among 558 patents, we discovered top 122 universities and scientific research institutions by total patent application. University of Miami, Yale University, University of Basel are dominant in this area. They take 17.20% of the total patent filing.
Connecticut, United States
Patent: 16
Basel-Stadt, Switzerland
Patent: 14
ZURICH, Switzerland
Patent: 14
North Carolina, United States
Patent: 6
Baylor College of Medicine
Texas, United States
Patent: 6
Nara Institute Of Science & Technology
Universidad Técnica Estatal de Quevedo
undefined undefined
Patent: 6
Minnesota, United States
Patent: 5
Council of Scientific & Industrial Research